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Abstract
Background—Children with chronic kidney disease (CKD) and hypertension have increased
blood pressure variability (BPV). Increased BPV has been associated with lower neurocognitive
test scores in adults. Children with CKD are at risk for decreased neurocognitive function. Our
objective was to determine if children with CKD and increased BPV had worse performance on
neurocognitive testing compared with children with CKD and lower BPV.
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Methods—This was a cross-sectional and longitudinal analysis of the relation between BPV and
neurocognitive test performance in children 6 years and older enrolled in the Chronic Kidney
Disease in Children (CKiD) study. Visit-to-visit BPV was assessed by the standard deviation of
visit BPs (BPV-SD) and average real variability (ARV). Ambulatory BPV was assessed by SD of
wake and sleep periods on 24hr ambulatory BP monitoring.
Results—650 subjects had a mean follow-up period of 4.0 years. Subjects with systolic visit-tovisit BPV in the upper tertile had lower scores on Delis–Kaplan Executive Function System (D-
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KEFS) Verbal Category Switching than those with BPV in the lower tertile (BPV-SD, 8.3 vs. 9.5,
p = 0.006; ARV, 8.5 vs. 9.6, p = 0.02). On multivariate analysis, the association between lower
Category Switching score and increased BPV remained significant after controlling for mean BP,
demographic characteristics, and disease-related variables (BPV-SD, β = −0.7, 95% confidence
interval [CI]: −1.28 to −0.12; ARV, CI: −1.05 to −0.02). Ambulatory BPV was not independently
associated with any cognitive measure.
Conclusions—Higher systolic visit-to-visit BPV was independently associated with decreased
D-KEFS Category Switching scores in children with mild-to-moderate CKD.
Keywords
Hypertension; pediatric; neuropsychological testing; kidney; CKD
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INTRODUCTION
In adults, alterations in blood pressure (BP) can have negative cardiovascular effects, not
only through elevations of mean BP, but also through increases in blood pressure variability
(BPV). BPV can be defined either in the short term, as measured by variability in
measurements within a 24 hour period during ambulatory BP monitoring (ambulatory BPV),
or in the long term as variability in office visit measurements over time (visit-to-visit BPV)
[1]. Studies show that increases in both short term and long term BPV are associated with
increases in hypertensive target organ damage, cardiovascular events, all-cause mortality,
and faster progression of chronic kidney disease (CKD) [2–6].
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Increased BPV may also affect neurocognitive function. In adults, visit-to-visit BPV and
ambulatory BPV have both been associated with lower scores in global cognition, executive
function, attention, processing speed and memory in the elderly [7–10]. Long term visit-tovisit BPV was evaluated over 25 years in a young adult cohort and was associated with
worse psychomotor speed and verbal memory in midlife, independent of cumulative BP
exposure [11].
Recently, ambulatory BPV was evaluated in children with mild-to-moderate CKD. Children
with CKD who were hypertensive were found to have increased BPV compared with those
who were normotensive [12]. Children with CKD are frequently hypertensive and are at risk
for decreased neurocognitive function [13]. To our knowledge, the potential impact of
increased BPV on cognition in children with CKD has not been previously evaluated. The
objective of the current study was to evaluate the impact of BPV on cognition in children
with mild-to-moderate CKD.
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METHODS
Participants
Subjects were participants in the Chronic Kidney Disease in Children Study (CKiD), a
longitudinal, observational cohort study of children with CKD being conducted at 48
pediatric nephrology centers in North America. Enrollment criteria for CKiD have been
published and include age 1 to 16 years and Schwartz-estimated GFR (eGFR) of 30 to 90
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ml/min per 1.73 m2, without solid organ, bone marrow, or stem cell transplant; dialysis
treatment within 3 months before enrollment; cancer/leukemia or HIV treatment; and
pregnancy [14]. This study is an analysis of CKiD subjects age 6 years and above for whom
both neurocognitive data and BP measurements were available and for whom there was at
least 2 years of BP data (3 visits). Subjects younger than 6 years were administered a
different neurocognitive test battery and were therefore excluded. CKiD study visits
occurred at study entry, at 6 months, and then annually from the time of initial enrollment,
with neurocognitive assessments occurring 6 months after enrollment, at 24 months, and
then every two years thereafter.
Measurements
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Casual Blood Pressure Measurement—Casual BP measurements were obtained in
the right arm by auscultation at each study visit by trained examiners. Training was repeated
annually. Three BP measurements were obtained by auscultation of the brachial artery using
the first Korotkoff sound for systolic BP (SBP) and the fifth Korotkoff sound for diastolic
BP (DBP). The average of the three BP measurements was recorded as the participant’s BP
for the study visit [15].
Ambulatory BP Monitoring
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Twenty-four hour ambulatory BP monitoring (ABPM) was performed at 6 months and then
every 2 years. For each 24hr recording, measurements were obtained every 20 minutes
through the day and night at a bleed step of 8 mm/Hg. A diary was kept during the
monitoring to record sleep and wake times. ABPM studies were considered successful only
when at least one successful BP measurement was obtained during each hour of monitoring
and the overall success rate was at least 75 %. The means of SBP and DBP were determined
for wake and sleep periods. BP index was defined as the mean BP divided by the 95th
percentile for that subject. Normative data for ABPM were based on American Heart
Association recommendations on ABPM for children and adolescents [16].
Blood Pressure Variability
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Long-term BPV was assessed by visit-to-visit variability, using the mean casual BP
measurement from each study visit leading up to and including the visit of the most recent
neurocognitive assessment for each subject. Because of subject age and study vintage, the
number of BP observations differed between subjects. Visit-to-visit BPV was assessed by
two methods: 1) the standard deviation of visit BPs (BPV-SD), and 2) average real
variability (ARV), with all BPs indexed to the 95th percentile for age, gender, and height for
that subject [17]. The ARV method quantifies variability between adjacent readings and is
defined by the following formula [6];

Short term BPV was evaluated using the ABPM session done prior to the most recent
neurocognitive testing. ABPM and neurocognitive assessments were not done concurrently
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at any point in the CKiD study; by study design ABPM sessions and neurocognitive
assessments were separated by 6 to 12 months. Ambulatory variability was measured as the
standard deviation of the mean SBP and DBP for the wake and sleep periods [12]. Standard
deviation of the 24hr mean BP was not used since that time period includes the nocturnal
dip. All ambulatory BP measures were indexed to the 95th percentile for gender and height
according to ambulatory norms [18].
Neurocognitive Assessments
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This analysis evaluated subject performance on selected measures from the CKiD
neurocognitive test battery, including Wechsler Abbreviated Scales of Intelligence (WASI)
Matrix Reasoning subtest, Conners’ Continuous Performance Test-II (CPT-II) commission
errors, and parent-rated Behavior Rating Inventory of Executive Function Global Executive
Composite (BRIEF GEC). These measures were chosen because it was previously shown
that CKiD participants were most likely to score more than 1 to 1.5 SD below the normative
mean on these measures, and they are measures that have been used throughout all the years
of the CKiD study [13]. In addition, based on the literature on hypertension and cognition,
Wechsler Intelligence Scale for Children-IV (WISC-IV) Digit Span and Delis–Kaplan
Executive Function System (D-KEFS) Verbal Fluency (Letter Fluency, Category Fluency,
Category Switching) were included as measures of working memory and cognitive speed/
efficiency. All of the assessments were administered or supervised by a licensed
psychologist who was not aware of the subject’s BP status. To ensure quality control,
neurocognitive data for the first two cases completed at each clinical site were reviewed by
the Clinical Coordinating Center neuropsychologists. Thereafter, 25 % of the assessments
were reviewed to verify administration fidelity, scoring accuracy, accuracy of translation of
raw scores into standardized scores, and accuracy of transcription. All of the measures in the
neurocognitive battery have good to excellent ratings of reliability [19].
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Analysis
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The data in this report are reported as the means ± SD, medians with interquartile ranges, or
frequencies and percentages, as appropriate. To address the primary research question,
whether children with increased BPV have poorer performance in measures of
neurocognitive function, test scores of the subjects with BPV in the upper tertile were
compared to those in the lower tertile in unadjusted analysis using 2-sided t tests. Systolic
BPV and diastolic BPV were analyzed separately. For each neurocognitive measure, the
score at the most recent neurocognitive assessment was evaluated so that the complete
observed history of BP measurements could be utilized. For cognitive measures with 3 or
more values over time, the annual change in score was also evaluated. This was not the case
for D-KEFS Verbal Fluency as it was added to the neurocognitive battery relatively recently,
thus limiting our ability to assess the annual change over time for that task. The D-KEFS
Category Switching scores were reported as Switching Total score, the average of Accuracy
and Total Correct scaled scores, since these scores correlated closely in our sample,
indicating overlap of the cognitive abilities being tested.
To assess the association between BPV and neurocognitive performance, multiple linear
regression was performed for each neurocognitive measure found to be different between the

Pediatr Nephrol. Author manuscript; available in PMC 2017 November 01.

Lande et al.

Page 5

Author Manuscript

BPV groups. In the models for visit-to-visit variability, the main predictor was
log2-transformed (BPV-SD or ARV), so the estimate can be interpreted as the change in
neurocognitive outcome per doubling of BPV-SD or ARV. In the models for ambulatory
variability, the main predictor is log2(ABPM SD), so the estimate can be interpreted as the
change in neurocognitive outcome per doubling of SD, adjusted for the covariates. The
multivariate analyses used all available BPV data, including the middle tertile, and evaluated
the log linear relation between BPV and neurocognitive measures. Other variables controlled
for in the regression models included mean corresponding BP index, sex, age, maternal
education, African-American race, body mass index (BMI) percentile, eGFR [20],
percentage of life with CKD, nephrotic proteinuria, and low birth weight. The significance
level for all data analyses was set at p < 0.05. SAS 9.2 (SAS Institute, Cary, NC) and S-Plus
8.2 (TIBCO Software, Palo Alto, CA) were used for analysis and figure generation.
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RESULTS
Sample Characteristics
The study sample comprised 650 participants. At the time of the most recent neurocognitive
assessment, the median age was 15.4 years, median duration of study follow-up was 4.0
years, and the median number of visits with casual BP measurement was 6. The sample was
62 % male, 22 % African-American, and the median eGFR was 47 ml/min/1.73m2. Table 1
shows sociodemographic and kidney disease-related characteristics of the sample. Figure 1
shows the median values and distribution of visit-to-visit systolic and diastolic BPV by both
the BP-SD and ARV methods.
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Visit-to-visit BPV and Neurocognitive Test Performance - Analysis of the most recent
neurocognitive assessment
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The number of subjects in each analysis varied by the particular neurocognitive test, ranging
from 279 for D-KEFS Category Switching to 622 for parent BRIEF GEC. Bivariate analysis
using the most recent neurocognitive assessment revealed that subjects with systolic visit-tovisit BPV in the upper tertile had lower scores (worse performance) on D-KEFS Verbal
Category Fluency and Category Switching compared with subjects with BPV in the lower
tertile, by both BPV-SD and ARV. In contrast, there was no significant difference between
systolic visit-to-visit BPV groups in any other neurocognitive measure (Table 2 and 3).
Multivariate linear regression analysis showed that increased systolic visit-to-visit BPV
remained independently associated with lower scores on the D-KEFS Verbal Category
Switching task for both BPV-SD and ARV, but not for Category Fluency (Table 4). Because
Category Switching was performed in only 279 subjects, we examined the difference in
demographics between those subjects with Category Switching and those who did not have
Category Switching performed (n = 371). Subjects with Category Switching had less
nephrotic proteinuria (11 % vs. 23 %, p <0.001), slightly shorter follow-up (3.8 vs. 4.1
years, p = 0.03), slightly lower average SBP index (0.87 vs. 0.87, p = 0.04), higher eGFR
(56 vs. 36, p <0.001), and less percentage of life with CKD (100 vs. 100 %, p = 0.04). We
adjusted for all of these demographic characteristics in the multivariate analyses. The group
with Category Switching also had a lower proportion of subjects with systolic BPV in the
upper tertile (BPV-SD, 27 vs 38 %, p = 0.02; ARV, 29 vs 36 %, p = 0.02).
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With regard to diastolic visit-to-visit BPV, bivariate analysis showed no difference between
groups for most measures, except a small difference in CPT-II commission errors (1st tertile
vs. 3rd tertile, 50.7 ± 12.4 vs. 52.6 ± 10.9, p = 0.04) for ARV, but not BPV-SD. However, the
difference by ARV did not remain significant after adjustment for covariates on multivariate
linear regression (β = −1.51, p = 0.07).
Visit-to-visit BPV - Analysis of the annual change in neurocognitive test performance
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Subjects with systolic visit-to-visit BPV in the upper tertile had slightly different annual
change in scores on the parent BRIEF GEC compared with subjects with BPV in the lower
tertile. However, these differences did not remain significant after adjustment for covariates
on multivariate linear regression (BPV-SD, β = −0.29, p = 0.35; ARV, β = −0.38, p = 0.16).
There were no other differences on bivariate analysis of systolic or diastolic BPV for any
neurocognitive measure using annual change in scores (data not shown). We were not able to
analyze the annual change in D-KEFS Verbal Fluency scores as too few subjects had at least
3 study visits with that measure.
Ambulatory BPV
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On analysis of the relation between ambulatory BPV and the most recent neurocognitive
assessment, the only statistically significant difference was for WASI Digit Span Forward
(systolic sleep, 1st vs. 3rd tertile, 8.0 ± 2.7 vs. 9.0 ± 3.0, p = 0.01; diastolic wake, 7.9 ± 2.8
vs. 9.0 ± 2.7, p = 0.005). However, these differences did not remain significant after
adjustment for covariates on multivariate linear regression (systolic sleep, β = 0.48, p = 0.27;
diastolic wake, β = 0.99, p = 0.11). On analysis of the relation between ambulatory BPV and
the annual change in neurocognitive test performance, the only statistically significant
difference was for the annual change in BRIEF GEC for systolic sleep (1st vs. 3rd tertile,
−0.13 ± 2.21 vs. −1.30 ± 2.80, p = 0.01). However, this difference did not remain significant
after adjustment for covariates on multivariate linear regression (β = −0.44, p = 0.34). There
was no difference for any other neurocognitive measure for any ABPM parameter (full data
for the ABPM bivariate and multivariate analyses are available in the Electronic
Supplementary Tables 1a–d and 2a–d).

DISCUSSION

Author Manuscript

This study was conducted to determine whether children with CKD and increased BPV had
poorer performance on selected tests of neurocognitive function when compared to the
performance of children with CKD and lower BPV, and to examine the relative contribution
of BPV to neurocognitive outcomes, taking into account mean BP and sociodemographic
and disease-related variables. The results showed that increased visit-to-visit systolic BPV in
children with mild-to-moderate CKD was independently associated with lower scores
(worse performance) on the Category Switching Task of the D-KEFS Verbal Fluency Test by
both BPV-SD and ARV.
In contrast, increased systolic visit-to-visit BPV was not associated with performance on any
of the other measures. No relation was uncovered between neurocognitive test performance
and diastolic visit-to-visit BPV in this sample. In contrast to the finding of an association
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between systolic visit-to-visit BPV and worse neurocognitive test performance, we did not
find any independent relation between ambulatory BPV and any neurocognitive measure.
However, these results were limited by the fact that the ABPM sessions in CKiD were
obtained 6 – 12 months apart from the neurocognitive testing, by study design. In addition, it
has been shown that the correlation between visit-to-visit BPV and ambulatory BPV is
weak, suggesting that they are not interchangeable entities [21].
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The D-KEFS Verbal Fluency Test was included in the current study because both CKD and
primary hypertension in adults have been associated with performance deficits in
neurocognitive measures of cognitive efficiency and processing speed [22, 23]. The
Category Switching subtest of the D-KEFS Verbal Fluency Test requires the subject to
alternate between saying words from two different semantic categories. Category switching
falls within a group of executive function tasks called set shifting, the mental ability to adjust
thinking or attention in response to changing expectations, goals, or environmental stimuli
[24]. The finding that children with CKD and increased long term BPV had worse
performance on the Category Switching Task suggests that children with CKD may have
difficulties with this component of executive functioning that are related, in part, to
increased BPV.
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This study has several limitations. Because D-KEFS Verbal Fluency was added to the CKiD
neurocognitive test battery only recently, we could not analyze the relationship between
increased BPV and the longitudinal annual change of Category Switching over time.
Therefore, the cross sectional nature of that part of the analysis limits inference about
causality between increased BPV and lower Category Switching scores. Although the
relation between increased BPV and lower Category Switching scores is intriguing, it is an
isolated finding. Other measures of verbal speed/cognitive efficiency and set shifting will
need to be examined in relation to elevated BPV in order to support the findings obtained
from this study. Nonetheless, our previous work suggests that measures of executive
function may be most sensitive to the effects of childhood CKD [25]. We excluded children
less than 6 years old. While younger age is associated with lower systolic BPV in children
with CKD [12], to our knowledge the effect of age on BPV in children with CKD who are
less than six years old has not been reported. Lastly, because the effects of BP on
neurocognitive test performance are known to be subtle, we did not adjust the bivariate
analysis for multiple comparisons. Although this approach permits the detection of more
subtle differences, it could increase the risk of a type 1 error.

Author Manuscript

In summary, we report the novel finding of an association between higher systolic visit-tovisit BPV and poorer neurocognitive function in children with CKD. This finding is
particularly notable given the mild-to-moderate degree of CKD in the participants. Further
studies are warranted to determine the significance of this isolated finding. The results are of
potential clinical significance, in that some antihypertensive medications lower BPV as well
as mean BP level [26]. Confirmation of these findings would raise the question as to whether
treating hypertension with medications that ameliorate BPV as well as lower mean BP level
would improve cognition, particularly cognitive flexibility, in children with CKD.
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Figure 1.

Median values and distribution of visit-to-visit systolic and diastolic BPV for both BP-SD
and ARV. All BPs were indexed to the 95th percentile for age, gender, and height for that
subject. The middle tertile is shaded in grey.
BPV: Blood pressure variability, BPV-SD: standard deviation of visit BPs, ARV: average
real variability, DBP: diastolic blood pressure, SBP: systolic blood pressure
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Author Manuscript

Demographic and kidney disease-related characteristics
Characteristic

Value

Age, y (median, IQR)

15.4 [12.1, 18]

Author Manuscript

Male (%, n)

62% (403)

African-American race (%, n)

22% (140)

Low birth weight (<2500 g) (%, n)

19% (117)

BMI percentile (median, IQR)

64 [31, 90]

eGFR (median, IQR)

47 [30, 64]

Nephrotic proteinuria (uP/C > 2) (%, n)

18% (107)

Glomerular etiology (%, n)

26% (167)

Percent of life with CKD (median, IQR)
Years in study (median, IQR)
Number of study visits (median, IQR)

100% [82%, 100%]
4.0 [2.1, 6.1]
6 [4, 8]

SBP Index (median, IQR)

0.87 [0.83, 0.92]

DBP Index (median, IQR)

0.82 [0.76, 0.88]

SBP or DBP ≥ 90th percentile

Author Manuscript

at most recent visit

152 (24%)

at any study visit

385 (59%)

Antihypertensive medication use (any)

463 (71%)

ACE inhibitor/ARB

363 (56%)

Calcium Channel Blocker

119 (18%)

Other

102 (16%)

ACE: Angiotensin converting enzyme, ARB: Angiotensin receptor blocker, BMI: Body mass index, CKD: chronic kidney disease, DBP: diastolic
blood pressure, eGFR: estimated glomerular filtration rate, IQR: interquartile range, SBP: systolic blood pressure
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Author Manuscript
475
475
281
281
279
279

Digit Span Reverse

Letter Fluency

Category Fluency

Category Switching*

Category Contrast**
−1.1 ± 3.4

9.5 ± 2.8

10.5 ± 3.4

9.2 ± 3.4

9.5 ± 3.1

8.7 ± 2.9

51.2 ± 12.2

53.1 ± 11.1

49.7 ± 10.5

1st tertile

−1.2 ± 3.4

9.4 ± 3.3

10.6 ± 3.4

9.4 ± 3.6

9.8 ± 3.3

8.4 ± 3.1

51.2 ± 12.0

53.4 ± 12.4

48.7 ± 10.7

2nd tertile

−1.0 ± 3.5

8.3 ± 3.0

9.3 ± 3.9

8.9 ± 3.2

9.1 ± 3.1

8.3 ± 2.9

52.1 ± 11.3

52.5 ± 11.8

48.6 ± 10.1

3rd tertile

Systolic BP standard deviation

0.92

0.006

0.03

0.55

0.36

0.28

0.46

0.58

0.31

p-value (1st vs. 3rd)

Contrast = Switching Scaled Score – Fluency Scaled Score. BP: blood pressure, BPV-SD: standard deviation of visit BPs, GEC: Global Executive Composite

**

average of Accuracy and Total scaled scores.

*

Note. Matrix Reasoning, GEC, and Errors of Commission are reported in T-Scores with a Mean = 50 and a Standard Deviation of 10. For Matrix Reasoning higher scores reflect a better performance; for
GEC and Errors of Commission higher scores reflect a worse performance. Digit Span and D-KEF tasks are reported in scaled scores with a Mean = 10 and a Standard Deviation of 3, with higher scores
reflecting a more intact performance.

487

622

GEC (parent or self)

Digit Span Forward

535

Matrix Reasoning

Errors of Commission

N

Neurocognitive Variable (at most recent visit)

Bivariate analysis comparing subjects with visit-to-visit systolic BPV-SD in the 3rd tertile to subjects in the 1st tertile
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Author Manuscript
475
475
281
281
279
279

Digit Span Reverse

Letter Fluency

Category Fluency

Category Switching

Category Contrast

−1.2 ± 3.7

9.6 ± 2.6

10.6 ± 3.5

9.4 ± 3.0

9.6 ± 3.1

8.6 ± 2.9

50.7 ± 12.4

52.7 ± 11.5

49.4 ± 10.9

1st tertile

−1.1 ± 3.4

9.2 ± 3.4

10.3 ± 3.4

9.5 ± 3.8

9.8 ± 3.4

8.6 ± 3.2

51.2 ± 12.1

52.7 ± 11.5

50.1 ± 9.4

2nd tertile

Systolic BP ARV

−1.0 ± 3.3

8.5 ± 3.2

9.5 ± 3.8

8.6 ± 3.5

9.0 ± 3.1

8.2 ± 2.8

52.6 ± 10.9

53.6 ± 12.2

47.7 ± 10.7

3rd tertile

0.70

0.02

0.03

0.08

0.09

0.17

0.16

0.44

0.13

p-value (1st vs. 3rd)

BP ARV: blood pressure average real variability, GEC: Global Executive Composite

Contrast = Switching – Fluency.

average of Accuracy and Total scaled scores.

**

*

Note. Matrix Reasoning, GEC, and Errors of Commission are reported in T-Scores with a Mean = 50 and a Standard Deviation of 10. For Matrix Reasoning higher scores reflect a better performance; for
GEC and Errors of Commission higher scores reflect a worse performance. Digit Span and D-KEF tasks are reported in scaled scores with a Mean = 10 and a Standard Deviation of 3, with higher scores
reflecting a more intact performance.

487

622

GEC (parent or self)

Digit Span Forward

535

Matrix Reasoning

Errors of Commission

N

Neurocognitive Variable (at most recent visit)

Bivariate analysis comparing subjects with visit-to-visit systolic ARV in the 3rd tertile to subjects in the 1st tertile.
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The association of increased indexed visit-to-visit BPV and Verbal Category Fluency and Category Switching
scores in separate multiple linear regression analyses for systolic BPV-SD and ARV.
Neurocognitive Variable (at most recent visit)

N

Visit-to-visit systolic BPV
Estimate

95% CI

p-value

BPV-SD

−0.21

(−0.92, 0.51)

0.57

ARV

−0.32

(−0.96, 0.32)

0.33

BPV-SD

−0.70

(−1.28, −0.12)

0.02

ARV

−0.54

(−1.05, −0.02)

0.04

Category Fluency

Category Switching

222

220

*

Author Manuscript

All regression models adjusted for mean corresponding BP index, sex, age, maternal education, African-American race, BMI percentile, eGFR,
percent of life with CKD, nephrotic proteinuria, and low birth weight.
ARV: average real variability, BMI: body mass index, BP: blood pressure, BPV: blood pressure variability, BPV-SD: standard deviation of visit
BPs, CI: confidence interval, CKD: chronic kidney disease, eGFR: estimated glomerular filtration rate
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